Wijsenbeek Marlies S, Culver Daniel A
Department of Pulmonary Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Clin Chest Med. 2015 Dec;36(4):751-67. doi: 10.1016/j.ccm.2015.08.015.
Treatment of sarcoidosis is not required in all patients with the diagnosis. The decision to treat and the strategy for how to treat usually require input and shared decision making by the patient. Some common consequences of sarcoidosis are not caused by granulomatous inflammation, but may be the dominant disease manifestation and should be actively considered when formulating a treatment plan. The medication regimen should be tailored to each patient. Steroid-sparing medications should be prescribed early as part of a long-term strategy.
并非所有确诊结节病的患者都需要接受治疗。是否进行治疗以及如何治疗的决策通常需要患者参与并共同做出决定。结节病的一些常见后果并非由肉芽肿性炎症引起，但可能是主要的疾病表现，在制定治疗方案时应积极予以考虑。药物治疗方案应根据每位患者的情况量身定制。作为长期策略的一部分，应尽早开具能减少类固醇使用的药物。
